Lately more and more investors are turning their attention, and more importantly their capital, to the psychedelics industry. Overall there are three reasons for this trend: A ´Global need for effective mental health treatments, evolving legislation and regulation, and somewhat broad support in the public.
In this session we will discuss the psychedelics space with a special focus on women’s health and are joined by Pamela Hadfield, the Co-founder of Eastra Health, the world’s first female-focused biotech company dedicated to developing psychedelic-derived medicines specifically for women.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on: